Literature DB >> 20959490

Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor.

Yulong Chen1, Jiong Deng, Junya Fujimoto, Humam Kadara, Taoyan Men, Dafna Lotan, Reuben Lotan.   

Abstract

Signal transducers and activators of transcription 3 (Stat3) is activated by cytokines and growth factors in lung cancers and regulates expression of genes implicated in cell growth, survival, and transformation. Previously, we found that mice with a deletion of the G protein-coupled receptor, family C, group 5, member a (Gprc5a) gene develop lung tumors, indicating that Gprc5a is a tumor suppressor. Herein, we show that epithelial cells from Gprc5a knockout mouse lung (Gprc5a(-/-) cells) survive better in vitro in medium deprived of exogenous growth factors and form more colonies in semisolid medium than their counterparts from wild-type mice (Gprc5a(+/+) cells). Stat3 tyrosine 705 phosphorylation and expression of several Stat3-regulated antiapoptotic genes were higher in Gprc5a(-/-) than in Gprc5a(+/+) cells. Both cell types secreted leukemia inhibitory factor (Lif); however, whereas Stat3 activation was persistent in Gprc5a(-/-) cells, it was transient in Gprc5a(+/+) cells. Lung adenocarcinoma cells isolated from Gprc5a(-/-) mice also exhibited autocrine Lif-mediated Stat3 activation. The level of Socs3, the endogenous Stat3 inhibitory protein, was higher in Gprc5a(+/+) than in Gprc5a(-/-) cells, and expression of the tumor suppressor stabilized Socs3. Inhibition of Stat3 signaling in Gprc5a(-/-) normal and cancer cells by the Janus-activated kinase 2 inhibitor AG490 or by a dominant negative Stat3(Y705F) increased starvation-induced apoptosis and inhibited colony formation. These results show that persistent Stat3 activation is important for the survival and transformation of Gprc5a(-/-) lung cells and suggest that the tumor suppressive effects of Gprc5a are mediated, at least in part, by inhibition of Stat3 signaling through Socs3 stabilization. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959490      PMCID: PMC2970717          DOI: 10.1158/0008-5472.CAN-10-0518

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Stat-3 is required for pulmonary homeostasis during hyperoxia.

Authors:  Isamu Hokuto; Machiko Ikegami; Mitsuhiro Yoshida; Kiyoshi Takeda; Shizuo Akira; Anne-Karina T Perl; William M Hull; Susan E Wert; Jeffrey A Whitsett
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 3.  The STATs of cancer--new molecular targets come of age.

Authors:  Hua Yu; Richard Jove
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

4.  Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.

Authors:  Lanxi Song; James Turkson; James G Karras; Richard Jove; Eric B Haura
Journal:  Oncogene       Date:  2003-07-03       Impact factor: 9.867

5.  Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation.

Authors:  J L Escary; J Perreau; D Duménil; S Ezine; P Brûlet
Journal:  Nature       Date:  1993-05-27       Impact factor: 49.962

6.  Human carcinoma cell lines produce biologically active leukemia inhibitory factor (LIF).

Authors:  H Kamohara; K Sakamoto; T Ishiko; S Mita; Y Masuda; T Abe; M Ogawa
Journal:  Res Commun Mol Pathol Pharmacol       Date:  1994-08

7.  Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways.

Authors:  P Kellokumpu-Lehtinen; M Talpaz; D Harris; Q Van; R Kurzrock; Z Estrov
Journal:  Int J Cancer       Date:  1996-05-16       Impact factor: 7.396

8.  SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.

Authors:  Biao He; Liang You; Kazutsugu Uematsu; Keling Zang; Zhidong Xu; Amie Y Lee; Joseph F Costello; Frank McCormick; David M Jablons
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-14       Impact factor: 11.205

Review 9.  Tyrosine kinases as targets for cancer therapy.

Authors:  Alexander Levitzki
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

10.  Colony morphology and growth in agarose as tests for spontaneous neoplastic transformation in vitro.

Authors:  R W Tucker; K K Sanford; S L Handleman; G M Jones
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

View more
  25 in total

1.  A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese.

Authors:  Zhibin Hu; Chen Wu; Yongyong Shi; Huan Guo; Xueying Zhao; Zhihua Yin; Lei Yang; Juncheng Dai; Lingmin Hu; Wen Tan; Zhiqiang Li; Qifei Deng; Jiucun Wang; Wei Wu; Guangfu Jin; Yue Jiang; Dianke Yu; Guoquan Zhou; Hongyan Chen; Peng Guan; Yijiang Chen; Yongqian Shu; Lin Xu; Xiangyang Liu; Li Liu; Ping Xu; Baohui Han; Chunxue Bai; Yuxia Zhao; Haibo Zhang; Ying Yan; Hongxia Ma; Jiaping Chen; Mingjie Chu; Feng Lu; Zhengdong Zhang; Feng Chen; Xinru Wang; Li Jin; Jiachun Lu; Baosen Zhou; Daru Lu; Tangchun Wu; Dongxin Lin; Hongbing Shen
Journal:  Nat Genet       Date:  2011-07-03       Impact factor: 38.330

2.  microRNA-367-3p regulation of GPRC5A is suppressed in ischemic stroke.

Authors:  Fatiha Tabet; Seyoung Lee; Wanying Zhu; Michael G Levin; Cynthia L Toth; Luisa F Cuesta Torres; Antony Vinh; Hyun Ah Kim; Hannah X Chu; Megan A Evans; Meaghan E Kuzmich; Grant R Drummond; Alan T Remaley; Kerry-Anne Rye; Christopher G Sobey; Kasey C Vickers
Journal:  J Cereb Blood Flow Metab       Date:  2019-07-11       Impact factor: 6.200

3.  RAI3 is overexpressed in gastric adenocarcinoma but unrelated to prognosis.

Authors:  Nathaniel Melling; Kai Bachmann; Maximillian Bockhorn; Oliver Mann; Jakob Robert Izbicki; Katharina Grupp
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

Review 4.  Harnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesis.

Authors:  Michael E Feigin
Journal:  FEBS J       Date:  2013-09-02       Impact factor: 5.542

5.  GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.

Authors:  Honggen Liu; Yunchao Zhang; Xuwen Hao; Fanming Kong; Xiaojiang Li; Jianchun Yu; Yingjie Jia
Journal:  Tumour Biol       Date:  2015-07-31

6.  Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.

Authors:  J Zheng; X Guo; X Gao; H Liu; Y Tu; Y Zhang
Journal:  Clin Transl Oncol       Date:  2013-04-30       Impact factor: 3.405

Review 7.  A Decade of GWAS Results in Lung Cancer.

Authors:  Yohan Bossé; Christopher I Amos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-14       Impact factor: 4.254

Review 8.  The emerging role of leukemia inhibitory factor in cancer and therapy.

Authors:  Cen Zhang; Juan Liu; Jianming Wang; Wenwei Hu; Zhaohui Feng
Journal:  Pharmacol Ther       Date:  2020-11-28       Impact factor: 12.310

9.  Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia.

Authors:  Tyrone Ryba; Dana Battaglia; Bill H Chang; James W Shirley; Quinton Buckley; Benjamin D Pope; Meenakshi Devidas; Brian J Druker; David M Gilbert
Journal:  Genome Res       Date:  2012-05-24       Impact factor: 9.043

10.  Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications.

Authors:  O Bucur; A L Stancu; R Khosravi-Far; A Almasan
Journal:  Cell Death Dis       Date:  2012-02-02       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.